Karla A. Lee

4.7k total citations
16 papers, 443 citations indexed

About

Karla A. Lee is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Karla A. Lee has authored 16 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Karla A. Lee's work include Gut microbiota and health (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Karla A. Lee is often cited by papers focused on Gut microbiota and health (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Karla A. Lee collaborates with scholars based in United Kingdom, Italy and United States. Karla A. Lee's co-authors include Véronique Bataille, Paul Nathan, Tim D. Spector, Heather M. Shaw, Timothy D. Spector, Heather Shaw, Claire J. Steves, Mary Ní Lochlainn, Alistair Robson and Stephen Johnston and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Karla A. Lee

16 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla A. Lee United Kingdom 10 186 158 90 51 43 16 443
Raluca Dumache Romania 14 54 0.3× 181 1.1× 67 0.7× 71 1.4× 57 1.3× 52 467
Marzanna Ciesielka Poland 9 96 0.5× 129 0.8× 175 1.9× 72 1.4× 25 0.6× 30 496
Robert D Nerenz United States 13 61 0.3× 155 1.0× 86 1.0× 22 0.4× 32 0.7× 42 545
Jordan Hindson Denmark 7 98 0.5× 124 0.8× 176 2.0× 59 1.2× 49 1.1× 88 484
Yongzhi Deng China 11 40 0.2× 115 0.7× 242 2.7× 59 1.2× 81 1.9× 34 555
Weihua Cai China 12 49 0.3× 195 1.2× 116 1.3× 33 0.6× 87 2.0× 27 417
Megha Gupta India 12 60 0.3× 57 0.4× 90 1.0× 22 0.4× 29 0.7× 47 505
Mohsen Rokni Iran 14 90 0.5× 129 0.8× 359 4.0× 36 0.7× 61 1.4× 23 651

Countries citing papers authored by Karla A. Lee

Since Specialization
Citations

This map shows the geographic impact of Karla A. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla A. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla A. Lee more than expected).

Fields of papers citing papers by Karla A. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla A. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla A. Lee. The network helps show where Karla A. Lee may publish in the future.

Co-authorship network of co-authors of Karla A. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Karla A. Lee. A scholar is included among the top collaborators of Karla A. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla A. Lee. Karla A. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Diop, Khoudia, Myriam Benlaïfaoui, Julie Malo, et al.. (2025). Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors. Gut Pathogens. 17(1). 21–21. 2 indexed citations
2.
Ibraheim, Hajir, et al.. (2024). The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy. Best Practice & Research Clinical Gastroenterology. 72. 101944–101944. 3 indexed citations
3.
Bolte, Laura A., Karla A. Lee, Johannes R. Björk, et al.. (2023). Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. JAMA Oncology. 9(5). 705–705. 51 indexed citations
4.
Shepherd, Scott T.C., Kabir Mohammed, Karla A. Lee, et al.. (2022). Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Breast Cancer Research and Treatment. 195(3). 333–340. 5 indexed citations
5.
Lee, Karla A., et al.. (2021). The gut microbiome: what the oncologist ought to know. British Journal of Cancer. 125(9). 1197–1209. 89 indexed citations
6.
Costeira, Ricardo, Karla A. Lee, Benjamin Murray, et al.. (2021). Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study. PLoS ONE. 16(9). e0257051–e0257051. 75 indexed citations
7.
Battisti, Nicolò Matteo Luca, María Sol Andrés, Karla A. Lee, et al.. (2021). Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer. Breast Cancer Research and Treatment. 188(1). 149–163. 45 indexed citations
8.
Lee, Karla A., Heather M. Shaw, Véronique Bataille, Paul Nathan, & Tim D. Spector. (2020). Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications. European Journal of Cancer. 138. 149–155. 62 indexed citations
9.
Österdahl, Marc F., Karla A. Lee, Mary Ní Lochlainn, et al.. (2020). Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR). BMC Infectious Diseases. 20(1). 783–783. 45 indexed citations
10.
Lee, Karla A., Heather M. Shaw, Véronique Bataille, & Paul Nathan. (2020). Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity. Journal for ImmunoTherapy of Cancer. 8(2). e000577–e000577. 10 indexed citations
12.
Lee, Karla A., Mansour T. A. Sharabiani, Dario Tumino, et al.. (2019). Differentiated Thyroid Cancer in Children: A UK Multicentre Review and Review of the Literature. Clinical Oncology. 31(6). 385–390. 16 indexed citations
13.
Lee, Karla A., Scott T.C. Shepherd, Nicolò Matteo Luca Battisti, et al.. (2019). Ado-trastuzumab Emtansine-Associated Spider Naevi in Metastatic HER2-positive Breast Cancer. Journal of Case Reports. 36–39. 1 indexed citations
14.
Lee, Karla A., et al.. (2019). Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab. BMJ Case Reports. 12(9). e228917–e228917. 24 indexed citations
15.
Lee, Karla A., Scott T.C. Shepherd, & Stephen Johnston. (2019). Abemaciclib, a Potent Cyclin-Dependent Kinase 4 and 6 Inhibitor, for Treatment of ER-Positive Metastatic Breast Cancer. Future Oncology. 15(29). 3309–3326. 11 indexed citations
16.
Lee, Karla A., Erik Mayer, & Vincent Khoo. (2017). Painful testicular metastasis from prostate adenocarcinoma. BMJ Case Reports. 2017. bcr–2017. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026